Fortis Lupin

Rediff.com » News » Fortis Lupin

News for Fortis Lupin

Business

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......

India business to put a spring in pharma's step

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels. Illustration: Uttam Ghosh/Rediff.com Analysts feel that revenue and EBIDTA growth in the pharmaceutical sector......

Budget 2023: What the pharma, healthcare industry seek

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......

Key mantra for India's pharma sector in 2023

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......

Covid: India's rich list swells; Ambani, Adani become wealthier

Forty Indians entered the billionaires' club in the pandemic-stricken 2020 to take the number of those in the coveted list to 177 people, a report said on Tuesday. Illustration: Uttam......

Rediff News

Fortis Lupin

News for Fortis Lupin

Lower input costs may aid pharma firms' Q2 margins

India business to put a spring in pharma's step

Budget 2023: What the pharma, healthcare industry seek

Key mantra for India's pharma sector in 2023

Covid: India's rich list swells; Ambani, Adani become wealthier

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS